This research study is designed to evaluate the effects of human umbilical cord mesenchymal stem cells (UC-MSCs), on Duchenne's muscular dystrophy (DMD). The potential muscle regenerative and anti-inflammatory properties of UC MSCs position them as a possible treatment option for DMD. Both of these properties could lead to potential benefits for a DMD patient.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
1
Asthma and Allergy Consultants
Wichita, Kansas, United States
Adverse Events
No occurrence of adverse events
Time frame: 3 months after final treatment
Change from baseline of weight
Time frame: 3 months after final treatment
Change of muscle diameter (circumferential measurements) from baseline
Time frame: 3 months after final treatment
Change from baseline of Pulmonary Maximum Expiratory Pressure
Time frame: 3 months after final treatment
Change from baseline of Pulmonary Forced Vital Capacity
Time frame: 3 months after final treatment
Maximum Change from baseline of Predicted Inspiratory Pressure %
Time frame: 3 months after final treatment
Change from baseline of Predicted Maximum Expiratory Pressure %
Time frame: 3 months after final treatment
Change from baseline of Predicted Forced Vital Capacity %
Time frame: 3 months after final treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.